Biodefense Market Size & Share 2022 to 2028

Market Size by Product (Vaccines {Anthrax, Smallpox, Botulism}, Biothreat Detection Devices {Samplers, Detectors/Triggering Devices, Identifiers, Assays and Reagents}) & Forecast.
Report ID: GMI714
   |
Published Date: April 2022
 | 
Report Format: PDF

Download Free PDF

Biodefense Market Size

Biodefense Market size surpassed USD 15.6 billion in 2021 and is expected to witness an 8.7% CAGR from 2022 to 2028 owing to the government-led several safety measures and stock vaccines to protect the economy from damages caused by bioterrorism attacks in developed countries.
 

Biodefense Market

Bioterrorism refers to the deliberate release of viruses, bacteria, and other hazardous germs with the potential to spread epidemics and cause death. This condition has a negative impact on the economy because it is harmful to human health and depletes human resources. As a result, governments in developed countries undertake a variety of efforts as well as preventative measures in order to withstand these attacks. Vaccines and biothreat detection technologies are frequently stocked by the government to ensure the safety of the population. Government initiatives like this will help to accelerate the biodefense market share.
 

The COVID-19 pandemic had a favorable influence on the biodefense market. The COVID-19 pandemic demonstrates how catastrophic biological events may result in significant human and economic loss, necessitating a nationwide response from numerous government and nonfederal agencies. There are several reasons to believe that the COVID-19 pandemic is an intentional act of bioterrorism. COVID-19 promises a huge potential for investment and income redistribution, similar to the swine flu epidemic of 2008-2009, when billions were created by major companies across the globe.
 

Bio-defenses is a combination of various processes and systems put in place by customs agents, bioscience laboratories, and other professionals to prevent the use of dangerous pathogens and toxins. Biodefense uses medical procedures to protect people against bioterrorism. The purposeful release of viruses, bacteria, or other organisms to cause sickness or death is referred to as a bioterrorism.
 

 

Biodefense Market Trends

During the analysis period, increasing technical breakthroughs will have a beneficial influence on the market growth. As a result of the rise in bioterrorism, prominent industry players have incorporated advancements to biothreat detection systems that aid in the effective identification of bacteria and viruses. The availability of technologically sophisticated biothreat detection technologies will safeguard the population's safety and security, boosting the market growth. However, low government R&D funding for creating vaccines against bioterrorism attacks in emerging and undeveloped nations may limit the growth of the biodefense market to some extent.
 

Biodefense Market Analysis

Global Biodefense Market By Product

Based on product, the biodefense market is bifurcated into vaccines, and biothreat detection devices. Vaccines are further segmented into botulism, smallpox, anthrax, and others.  Whereas biothreat detection devices are further segmented into detectors/triggering devices, samplers, assays, reagents, and identifiers. Among these the vaccines segment accounted for around 64.5% market share in 2021 owing to increasing vaccines production across the globe to prevent spread of various viruses.
 

Furthermore, researchers are currently investigating novel vaccine technologies, such as vector technology, in order to induce rapid protection against pathogen attack will spur the biodefense market growth. Recently developed vaccines had the ability to address a wide range of bioterrorism chemicals and can induce a long-lasting immune response after a single oral dose. Also, several countries have witnessed a surging Ebola virus, Zika and COVID-19 infections and therefore many companies are competing to develop vaccines.
 

North America Biodefense Market By Country

North America biodefense market captured over 41.6% revenue share in 2021 and is poised to grow substantially during the forthcoming years owing to growing importance of biodefense and the rising threat of harmful biological materials. Furthermore, the U.S is one of the region's most developed biodefense marketplaces, with well-established vaccine production facilities.
 

Additionally, U.S. government implements several initiatives that helps them in strengthening security against bioterrorism attacks. Government plans several biodefense programs such as pandemic influenza and infectious disease program. Other factors such as growing adoption of technological advanced product coupled with rising awareness regarding biodefense among the individuals will spur the regional market forecasts.
 

Biodefense Market Share

Some of the key market players operating in the biodefense industry include

  • Alexeter Technologies, LLC
  • Altimmune
  • ANP Technologies
  • Bavarian Nordic
  • BioFire Defense (bioMérieux SA)
  • Biosearch Technologies
  • Bruker Detection
  • Electronic Sensor Technology Inc.
  • Elusys Therapeutics
  • Emergent BioSolutions
  • Ichor Medical Systems, Inc.
  • Nanologix
  • New Horizon Diagnostic Corp.
  • PositiveID Corporation
  • SIGA Technologies
  • Smiths Detection Group Ltd.
  • Synexis Systems

These market players are employing a variety of development strategies, including continual innovation and technological advancements, in order to maintain business rivalry in the biodefense market.
 

Some of the recent industry developments:

  • In February 2022, Appili Therapeutics Inc. announced funding of over USD 10 million to advance their biodefense vaccine candidate i.e., ATI-1701 for the prevention of infection with Francisella tularensis. This is projected to boost company presence and biodefense market growth.
     
  • In August 2018, CEPI (the Coalition for Epidemic Preparedness Innovations) announced a new collaboration with Profectus BioSciences, Inc. and Emergent BioSolutions Inc. to advance the development and manufacture of a vaccine against the Lassa virus. This collaboration helped companies in advancement of product portfolio thus increasing its sales.
     

The biodefense market report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2022 to 2028, for the following segments:

By Product

  • Vaccines
    • Anthrax
    • Smallpox
    • Botulism
    • Others
  • Biothreat Detection Devices
    • Samplers
    • Detectors/Triggering Devices
    • Identifiers
    • Assays and Reagents

The above information is provided for the following regions and countries:

By Region

  • North America 
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
  • Asia Pacific 
    • Japan
    • China
    • India
    • Australia
  • Latin America 
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa 
    • South Africa
    • Saudi Arabia
    • UAE

 

Authors: Monali Tayade, Jignesh Rawal
Biodefense Market Scope
  • Biodefense Market Size
  • Biodefense Market Trends
  • Biodefense Market Analysis
  • Biodefense Market Share

Report Content

Chapter 1   Methodology

1.1    Methodology

1.2    Market definitions

1.3    Forecast parameters

1.4    Data sources

1.4.1    Secondary

1.4.1.1    Paid sources

1.4.1.2    Unpaid sources

1.4.2    Primary

Chapter 2   Executive Summary

2.1    Biodefense industry 360° synopsis, 2017 - 2028

2.1.1    Business trends

2.1.2    Product trends

2.1.3    Regional trends

Chapter 3   Biodefense Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2017 - 2028

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Technological advancements in biotechnology sector in North America and Europe

3.3.1.2    Favorable government initiatives in Asia Pacific and Latin America

3.3.1.3    Growing investments by government in R&D in North America & Europe

3.3.2    Industry pitfalls & challenges

3.3.2.1    Low R&D funding by government in underdeveloped regions

3.4    Growth potential analysis

3.4.1    By product

3.5    COVID-19 impact analysis

3.6    Porter’s analysis

3.7    Competitive landscape, 2021

3.7.1    Company matrix analysis, 2021

3.8    PESTEL analysis

Chapter 4   Biodefense Market, By Product

4.1    Key segment trends

4.2    Vaccines

4.2.1    Market size, by region, 2017 - 2028 (USD Million)

4.2.2    Anthrax

4.2.2.1    Market size, by region, 2017 - 2028 (USD Million)

4.2.3    Smallpox

4.2.3.1    Market size, by region, 2017 - 2028 (USD Million)

4.2.4    Botulism

4.2.4.1    Market size, by region, 2017 - 2028 (USD Million)

4.2.5    Others

4.2.5.1    Market size, by region, 2017 - 2028 (USD Million)

4.3    Biothreat detection devices

4.3.1    Market size, by region, 2017 - 2028 (USD Million)

4.3.2    Samplers

4.3.2.1    Market size, by region, 2017 - 2028 (USD Million)

4.3.3    Detectors/triggering devices

4.3.3.1    Market size, by region, 2017 - 2028 (USD Million)

4.3.4    Identifiers

4.3.4.1    Market size, by region, 2017 - 2028 (USD Million)

4.3.5    Assays and reagents

4.3.5.1    Market size, by region, 2017 - 2028 (USD Million)

Chapter 5   Biodefense Market, By Region

5.1    Key regional trends

5.2    North America

5.2.1    Market size, by country, 2017 - 2028 (USD Million)

5.2.2    Market size, by product, 2017 - 2028 (USD Million)

5.2.2.1    Market size, by vaccines, 2017 - 2028 (USD Million)

5.2.2.2    Market size, by biothreat detection devices, 2017 - 2028 (USD Million)

5.2.3    U.S.

5.2.3.1    Market size, by product, 2017 - 2028 (USD Million)

5.2.3.1.1    Market size, by vaccines, 2017 - 2028 (USD Million)

5.2.3.1.2    Market size, by biothreat detection devices, 2017 - 2028 (USD Million)

5.2.4    Canada

5.2.4.1    Market size, by product, 2017 - 2028 (USD Million)

5.2.4.1.1    Market size, by vaccines, 2017 - 2028 (USD Million)

5.2.4.1.2    Market size, by biothreat detection devices, 2017 - 2028 (USD Million)

5.3    Europe

5.3.1    Market size, by country, 2017 - 2028 (USD Million)

5.3.2    Market size, by Product, 2017 - 2028 (USD Million)

5.3.2.1    Market size, by vaccines, 2017 - 2028 (USD Million)

5.3.2.2    Market size, by biothreat detection devices, 2017 - 2028 (USD Million)

5.3.3    Germany

5.3.3.1    Market size, by product, 2017 - 2028 (USD Million)

5.3.3.1.1    Market size, by vaccines, 2017 - 2028 (USD Million)

5.3.3.1.2    Market size, by biothreat detection devices, 2017 - 2028 (USD Million)

5.3.4    UK

5.3.4.1    Market size, by product, 2017 - 2028 (USD Million)

5.3.4.1.1    Market size, by vaccines, 2017 - 2028 (USD Million)

5.3.4.1.2    Market size, by biothreat detection devices, 2017 - 2028 (USD Million)

5.3.5    France

5.3.5.1    Market size, by product, 2017 - 2028 (USD Million)

5.3.5.1.1    Market size, by vaccines, 2017 - 2028 (USD Million)

5.3.5.1.2    Market size, by biothreat detection devices, 2017 - 2028 (USD Million)

5.3.6    Spain

5.3.6.1    Market size, by product, 2017 - 2028 (USD Million)

5.3.6.1.1    Market size, by vaccines, 2017 - 2028 (USD Million)

5.3.6.1.2    Market size, by biothreat detection devices, 2017 - 2028 (USD Million)

5.4    Asia Pacific

5.4.1    Market size, by country, 2017 - 2028 (USD Million)

5.4.2    Market size, by product, 2017 - 2028 (USD Million)

5.4.2.1    Market size, by vaccines, 2017 - 2028 (USD Million)

5.4.2.2    Market size, by biothreat detection devices, 2017 - 2028 (USD Million)

5.4.3    Japan

5.4.3.1    Market size, by product, 2017 - 2028 (USD Million)

5.4.3.1.1    Market size, by vaccines, 2017 - 2028 (USD Million)

5.4.3.1.2    Market size, by biothreat detection devices, 2017 - 2028 (USD Million)

5.4.4    China

5.4.4.1    Market size, by product, 2017 - 2028 (USD Million)

5.4.4.1.1    Market size, by vaccines, 2017 - 2028 (USD Million)

5.4.4.1.2    Market size, by biothreat detection devices, 2017 - 2028 (USD Million)

5.4.5    India

5.4.5.1    Market size, by product, 2017 - 2028 (USD Million)

5.4.5.1.1    Market size, by vaccines, 2017 - 2028 (USD Million)

5.4.5.1.2    Market size, by biothreat detection devices, 2017 - 2028 (USD Million)

5.5    Latin America

5.5.1    Market size, by country, 2017 - 2028 (USD Million)

5.5.2    Market size, by product, 2017 - 2028 (USD Million)

5.5.2.1    Market size, by vaccines, 2017 - 2028 (USD Million)

5.5.2.2    Market size, by biothreat detection devices, 2017 - 2028 (USD Million)

5.5.3    Brazil

5.5.3.1    Market size, by product, 2017 - 2028 (USD Million)

5.5.3.1.1    Market size, by vaccines, 2017 - 2028 (USD Million)

5.5.3.1.2    Market size, by biothreat detection devices, 2017 - 2028 (USD Million)

5.5.4    Mexico

5.5.4.1    Market size, by product, 2017 - 2028 (USD Million)

5.5.4.1.1    Market size, by vaccines, 2017 - 2028 (USD Million)

5.5.4.1.2    Market size, by biothreat detection devices, 2017 - 2028 (USD Million)

5.5.5    Argentina

5.5.5.1    Market size, by product, 2017 - 2028 (USD Million)

5.5.5.1.1    Market size, by vaccines, 2017 - 2028 (USD Million)

5.5.5.1.2    Market size, by biothreat detection devices, 2017 - 2028 (USD Million)

5.6    MEA

5.6.1    Market size, by country, 2017 - 2028 (USD Million)

5.6.2    Market size, by product, 2017 - 2028 (USD Million)

5.6.2.1    Market size, by vaccines, 2017 - 2028 (USD Million)

5.6.2.2    Market size, by biothreat detection devices, 2017 - 2028 (USD Million)

5.6.3    South Africa

5.6.3.1    Market size, by product, 2017 - 2028 (USD Million)

5.6.3.1.1    Market size, by vaccines, 2017 - 2028 (USD Million)

5.6.3.1.2    Market size, by biothreat detection devices, 2017 - 2028 (USD Million)

5.6.4    Saudi Arabia

5.6.4.1    Market size, by product, 2017 - 2028 (USD Million)

5.6.4.1.1    Market size, by vaccines, 2017 - 2028 (USD Million)

5.6.4.1.2    Market size, by biothreat detection devices, 2017 - 2028 (USD Million)

5.6.5    UAE

5.6.5.1    Market size, by product, 2017 - 2028 (USD Million)

5.6.5.1.1    Market size, by vaccines, 2017 - 2028 (USD Million)

5.6.5.1.2    Market size, by biothreat detection devices, 2017 - 2028 (USD Million)

Chapter 6   Company Profiles

6.1    Strategy dashboard, 2021

6.2    Alexeter Technologies, LLC

6.2.1    Business overview

6.2.2    Financial data

6.2.3    Product landscape

6.2.4    Strategic outlook

6.2.5    SWOT analysis

6.3    Altimmune

6.3.1    Business overview

6.3.2    Financial data

6.3.3    Product landscape

6.3.4    Strategic outlook

6.3.5    SWOT analysis

6.4    ANP Technologies

6.4.1    Business overview

6.4.2    Financial data

6.4.3    Product landscape

6.4.4    Strategic outlook

6.4.5    SWOT analysis

6.5    Bavarian Nordic

6.5.1    Business overview

6.5.2    Financial data

6.5.3    Product landscape

6.5.4    Strategic outlook

6.5.5    SWOT analysis

6.6    BioFire Defense (bioMérieux SA)

6.6.1    Business overview

6.6.2    Financial data

6.6.3    Product landscape

6.6.4    Strategic outlook

6.6.5    SWOT analysis

6.7    Biosearch Technologies

6.7.1    Business overview

6.7.2    Financial data

6.7.3    Product landscape

6.7.4    Strategic outlook

6.7.5    SWOT analysis

6.8    Bruker Detection

6.8.1    Business overview

6.8.2    Financial data

6.8.3    Product landscape

6.8.4    Strategic outlook

6.8.5    SWOT analysis

6.9    Electronic Sensor Technology Inc.

6.9.1    Business overview

6.9.2    Financial data

6.9.3    Product landscape

6.9.4    Strategic outlook

6.9.5    SWOT analysis

6.10    Elusys Therapeutics

6.10.1    Business overview

6.10.2    Financial data

6.10.3    Product landscape

6.10.4    Strategic outlook

6.10.5    SWOT analysis

6.11    Emergent BioSolutions

6.11.1    Business overview

6.11.2    Financial data

6.11.3    Product landscape

6.11.4    Strategic outlook

6.11.5    SWOT analysis

6.12    Ichor Medical Systems, Inc.

6.12.1    Business overview

6.12.2    Financial data

6.12.3    Product landscape

6.12.4    Strategic outlook

6.12.5    SWOT analysis

6.13    Nanologix

6.13.1    Business overview

6.13.2    Financial data

6.13.3    Product landscape

6.13.4    Strategic outlook

6.13.5    SWOT analysis

6.14    New Horizon Diagnostic Corp.

6.14.1    Business overview

6.14.2    Financial data

6.14.3    Product landscape

6.14.4    Strategic outlook

6.14.5    SWOT analysis

6.15    PositiveID Corporation

6.15.1    Business overview

6.15.2    Financial data

6.15.3    Product landscape

6.15.4    Strategic outlook

6.15.5    SWOT analysis

6.16    SIGA Technologies

6.16.1    Business overview

6.16.2    Financial data

6.16.3    Product landscape

6.16.4    Strategic outlook

6.16.5    SWOT analysis

6.17    Smiths Detection Group Ltd.

6.17.1    Business overview

6.17.2    Financial data

6.17.3    Product landscape

6.17.4    Strategic outlook

6.17.5    SWOT analysis

6.18    Synexis Systems

6.18.1    Business overview

6.18.2    Financial data

6.18.3    Product landscape

6.18.4    Strategic outlook

6.18.5    SWOT analysis

Don't see your key competitors?

The companies listed in this report are a curated selection - not the full competitive universe.

Our market revenue calculations use a bottom-up methodology that accounts for all players across all regions - including manufacturers, distributors, and specialists not individually profiled. The profiles section spotlights strategically significant players; it does not define the scope of our market sizing.

Your competitive landscape may also include

Regional or domestic-only leaders not in the global top tier
Distributors and channel partners who control market access
Emerging disruptors, startups, or adjacent-industry entrants
Niche players focused on a specific application or end-use

Free customization - up to 20% of report value

Need specific data? Request customization and get the insights tailored to your exact requirements.

Authors: Monali Tayade, Jignesh Rawal

For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at [email protected]

Explore Our Licensing Options:

Starting at: $2,450

Immediate Delivery Available

Premium Report Details

Base Year: 2021

Companies covered: 17

Tables & Figures: 172

Countries covered: 16

Pages: 110

Download Free PDF

img

Biodefense Market

Get a free sample of this report
country Flag
+1
img
Get a free sample of this report Biodefense Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Your personal details will remain secure and confidential.

Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!